DT

Daniel Tillett

Racura Oncology Ltd | Chief Executive Officer, Managing Director
Dr Tillett is the Managing Director and Chief Executive Officer of Racura Oncology. He is a veteran executive in the biotech industry with more than 25 years of management experience and leadership in all aspects of commercial operations including strategy, IP management, sales and marketing, project management, licensing and fundraising. Dr Tillett is the founder and CEO of Nucleics, a private Australian biotechnology company producing and selling DNA sequencing software to the genomics industry. Previously, he was a Senior Lecturer within the School of Pharmacy at La Trobe University.

Companies and Roles

Company
Title
Tenure
Since
RAC
RAC
Racura Oncology Ltd
  • Chief Executive Officer
  • Managing Director
7yrs, 1mthSep 2019
ENP
ENP
Entropy Neurodynamics Limited
  • Non-Executive Director
1yrs, 11mthNov 2024

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RAC
RAC
Racura Oncology Ltd
25/09/2620,184,351103,0005,028,493N/A
ENP
ENP
Entropy Neurodynamics Limited
30/06/2667,000,000N/A47,250,000N/A
TYP
TYP
30/06/2562,000,000N/A12,250,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RAC
RAC
Racura Oncology Ltd
25/09/26
Buy
23,000$1.987$45,701On-market trade
RAC
RAC
Racura Oncology Ltd
22/09/26
Buy
80,000$2.038$163,040On-market trade
RAC
RAC
Racura Oncology Ltd
22/09/26
Sell
89,500$2.008$179,716On-market trade
RAC
RAC
Racura Oncology Ltd
22/09/26
Buy
4,500$2.038$9,171On-market trade
RAC
RAC
Racura Oncology Ltd
28/05/26
Buy
400,000$1.250$500,000Exercise of options